Cargando…
Why Iron Deficiency in Acute Heart Failure Should Be Treated: A Real-World Clinical Practice Study
Background. This study aims to determine whether the administration of ferric carboxymaltose (FCM) in patients with acute heart failure (AHF) and iron deficiency (ID) improves morbidity and mortality. Methods. We studied 890 consecutive patients admitted for AHF. Patients were divided into six group...
Autores principales: | López-Vilella, Raquel, Donoso Trenado, Víctor, Jover Pastor, Pablo, Sánchez-Lázaro, Ignacio, Martínez Dolz, Luis, Almenar Bonet, Luis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699465/ https://www.ncbi.nlm.nih.gov/pubmed/36362983 http://dx.doi.org/10.3390/life12111828 |
Ejemplares similares
-
Is the Benefit of Treating Iron Deficiency Greater in Acute Heart Failure with Renal Dysfunction?
por: López-Vilella, Raquel, et al.
Publicado: (2023) -
COVID-19 Infection in Heart Transplants in Pre- and Postvaccination Periods
por: Donoso Trenado, Víctor, et al.
Publicado: (2022) -
COVID-19 and Heart Transplantation. Initial Experience in a Tertiary Hospital
por: López-Vilella, Raquel, et al.
Publicado: (2021) -
The Female Sex Confers Different Prognosis in Heart Failure: Same Mortality but More Readmissions
por: López-Vilella, Raquel, et al.
Publicado: (2021) -
Therapeutic approach in heart failure with poor diuretic response: peripheral ultrafiltration vs. conventional treatment
por: López‐Vilella, Raquel, et al.
Publicado: (2023)